Study S000888

A Randomized Controlled Pilot Study of Polyethylene Glycol Loxenatide Plus LNG-IUS in Women With Endometrial Atypical Hyperplasia

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT05172999
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2; PHASE3
Masking: NONE
Status: COMPLETED
Enrollment: 30
Start: 2022-01-08
Primary completion: 2025-12-30
Lead sponsor: Fudan University
Conditions: Atypical Endometrial Hyperplasia; Obesity; Fertility Issues
Interventions: DEVICE:levonorgestrel-releasing intrauterine system; DRUG:Polyethylene Glycol Loxenatide
Results posted: FALSE

Registered primary outcomes

Pathological complete response (CR) rates [From date of randomization until the date of CR, assessed up to 32 weeks.]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.